[{"id":0,"href":"/docs/algorithms/Genetic-Algorithm/","title":"Genetic Algorithm","section":"Algorithms","content":"\rGenetic Algorithm\r#\r"},{"id":1,"href":"/docs/algorithms/","title":"Algorithms","section":"Docs","content":"\rContent\r#\r"},{"id":2,"href":"/docs/content/bioinformatics/","title":"Bioinformatics","section":"Docs","content":"\rIntroduction to Bioinformatics\r#\rTable of Content:\r#\rSequence Assembly Sequence Alignment Genomics Epigenomics Transcriptomics Proteomics Microbiomics Metagenomics Phylogenetics Structural Bioinformatics Machine Learning "},{"id":3,"href":"/docs/content/pharmacology/","title":"Pharmacology","section":"Docs","content":"\rIntroduction to Pharmacology\r#\rTerminologies\r#\rTerms Description Pharmacokinetics The study of how the body affects a drug. Pharmacodynamics The study of how drugs exert their effects on the body. Toxicology The study of adverse effects of drugs. Pharmacogenomics The study of how an individual\u0026rsquo;s genetic makeup influences their response to drugs. What is Pharmacology?\r#\rPharmacology is the study of drugs and their effects on living organisms, which can be subdivided into:\nPharmacokinetics Pharmacodynamics Toxicology Pharmacogenomics Pharmacokinetics\r#\rPharmacokinetics is the study of how the body affects a drug. It involves understanding the processes of absorption, distribution, metabolism, and excretion (ADME) of drugs within the body. Pharmacokinetic parameters help determine the optimal dosing regimen and predict drug concentrations in various tissues over time.\nEven the most promising pharmacologic therapies will fail in clinical trials if the drug is unable to reach its target organ at a concentration sufficient to have a therapeutic effect.\nPharmacodynamics\r#\rPharmacodynamics is the study of how drugs exert their effects on the body. It explores dosage, mechanisms of action, and activity of drugs, including receptor binding, signal transduction pathways, and resulting pharmacological responses.\nToxicology\r#\rToxicology is the study of adverse effects of drugs, chemicals, and other substances on living organisms. It involves assessing the potential toxicity of substances, identifying toxic mechanisms, and determining safe exposure levels.\nPharmacogenomics\r#\rPharmacogenomics is the study of how an individual\u0026rsquo;s genetic makeup influences their response to drugs. It involves identifying genetic variations that affect drug metabolism, efficacy, and toxicity, thereby maximizing efficacy and minimizing adverse reactions.\nReferences:\r#\rADME Pharmacodynamics Brief Description About This Tutorial:\r#\rBiology background not required. Terminologies highlighted with definitions. Practice questions at the end of each section with answers. Learn at your own pace. Visit the reference page to navigate to the page about your drug of interest.\nIntroduction to Pharmacology\r#\rDefinition and Scope\r#\rIntroduce the concept of pharmacology and its importance in healthcare. Discuss the scope, including drug discovery, development, mechanisms of action, and clinical applications. Historical Perspective\r#\rBriefly cover the historical milestones in pharmacology, from ancient remedies to modern drug development. Basic Concepts\r#\rDefine important terms: drug, pharmacokinetics, pharmacodynamics, dose-response relationships, etc. Introduce principles of drug administration and absorption. Pharmacokinetics\r#\rAbsorption\r#\rRoutes of drug administration (oral, parenteral, topical, inhalation, etc.). Factors affecting drug absorption (e.g., bioavailability, first-pass metabolism). Distribution\r#\rDrug distribution within the body (plasma protein binding, tissue penetration). Factors affecting drug distribution (e.g., tissue perfusion, protein binding). Metabolism\r#\rIntroduction to drug metabolism, including phase I and phase II reactions. Factors influencing drug metabolism (e.g., genetic polymorphisms, drug-drug interactions). Excretion\r#\rMechanisms of drug excretion (renal, hepatic, pulmonary, etc.). Factors influencing drug excretion. Pharmacodynamics\r#\rDrug-Receptor Interactions\r#\rIntroduction to receptors and their classification. Mechanisms of drug-receptor interactions (agonists, antagonists, partial agonists, etc.). Signal Transduction\r#\rOverview of cellular signaling pathways affected by drugs. Examples of common signal transduction pathways targeted by drugs (e.g., G protein-coupled receptors, enzyme-linked receptors). Dose-Response Relationships\r#\rIntroduction to dose-response curves. Types of dose-response relationships (linear, sigmoidal, etc.). Potency vs. efficacy. Drug Toxicity and Adverse Effects\r#\rDifferentiate between side effects, adverse effects, and toxicity. Factors influencing drug toxicity (dose, duration of exposure, patient characteristics). Pharmacotherapeutics\r#\rDrug Classes\r#\rClassification of drugs based on therapeutic uses (e.g., analgesics, antibiotics, antihypertensives, etc.). Mechanisms of action and clinical applications of major drug classes. Treatment Guidelines\r#\rEvidence-based approach to pharmacotherapy. Principles of rational drug use and prescribing. Individual Variation in Drug Response\r#\rGenetic factors influencing drug response (pharmacogenomics). Age, sex, and other patient-related factors affecting drug response. Special Topics\r#\rPharmacoeconomics\r#\rIntroduction to pharmacoeconomic principles. Cost-effectiveness analysis, budget impact analysis, etc. Drug Development and Regulation\r#\rOverview of the drug development process. Regulatory aspects (FDA, EMA, etc.) and drug approval procedures. Drug Interactions\r#\rTypes of drug interactions (pharmacokinetic vs. pharmacodynamic). Clinical implications and management of drug interactions. "},{"id":4,"href":"/docs/content/bioinformatics/sequence_assembly/","title":"Sequence Assembly","section":"Bioinformatics","content":"\rWhat is Sequence Assembly?\r#\rSequence assembly is a fundamental process in bioinformatics that involves reconstructing longer DNA sequences from smaller fragments, often called reads. This process is essential for determining the genome structure of organisms, understanding genetic variation, and conducting various genomics studies. By piecing together these fragments, sequence assembly provides a comprehensive view of an organism\u0026rsquo;s genetic makeup, even when individual DNA strands are too short to be read directly.\nThe primary challenge in sequence assembly arises from the fact that the sequencing technologies used today generate short reads, often ranging from 100 to 500 base pairs. These short fragments need to be aligned and merged to form a continuous, accurate sequence. This process is crucial for various applications, including whole genome sequencing, transcriptome analysis, and metagenomic studies.\nTypes of Sequence Assembly\r#\rThere are two main approaches to sequence assembly: de novo assembly and reference-guided assembly.\n1. De Novo Assembly\r#\rDe novo assembly is the process of assembling the sequence without any prior knowledge of the organism\u0026rsquo;s genome. This method is particularly useful when studying novel or poorly characterized organisms. In de novo assembly, the assembler must align the short fragments (or reads) to build longer sequences (contigs). The process often requires sophisticated algorithms to deal with repetitive DNA sequences and ensure the assembly is accurate and complete.\nKey Steps in De Novo Assembly:\r#\rRead Alignment: Aligning the short reads to identify overlaps. Contig Construction: Combining overlapping reads to create contiguous sequences (contigs). Scaffolding: Linking contigs together to form larger structures, known as scaffolds. Polishing: Refining the assembly by correcting errors and filling gaps. 2. Reference-Guided Assembly\r#\rReference-guided assembly, also known as mapping-based assembly, involves aligning the short reads to a reference genome. This method is typically faster and more accurate than de novo assembly, as it leverages existing genomic information to guide the assembly process. It\u0026rsquo;s commonly used in applications such as resequencing, where the goal is to study an organism\u0026rsquo;s genome in relation to a known reference genome.\nKey Steps in Reference-Guided Assembly:\r#\rRead Alignment: Mapping the reads to the reference genome. Error Correction: Identifying and correcting discrepancies between the reads and the reference. Variant Calling: Detecting genetic variations (e.g., SNPs, indels) compared to the reference. Importance of Sequence Assembly\r#\rSequence assembly is crucial for several areas of biological research, including:\nGenomics: It enables the complete sequencing of genomes, providing insight into genetic diversity and evolution. Metagenomics: In microbial community studies, sequence assembly is used to reconstruct genomes from environmental samples, allowing researchers to explore the genetic makeup of complex microbial ecosystems. Cancer Genomics: Sequence assembly is vital for identifying mutations and structural variations that may be implicated in cancer. Personalized Medicine: By assembling the genomes of individuals, researchers can identify genetic variants that influence disease susceptibility and drug response. Tools and Algorithms for Sequence Assembly\r#\rThere are several software tools and algorithms designed for sequence assembly. These tools vary in terms of their approach, accuracy, and computational requirements. Some of the widely used tools include:\nSPAdes: A popular de novo assembler known for its high accuracy in assembling genomes. Velvet: Another de novo assembler that is highly efficient for assembling short reads. BWA (Burrows-Wheeler Aligner): A widely used reference-guided assembler for mapping reads to a reference genome. Bowtie2: A fast and memory-efficient aligner used for mapping short reads to large genomes. Challenges in Sequence Assembly\r#\rDespite advancements in sequencing technology and computational methods, sequence assembly remains a complex and computationally intensive task. Some of the main challenges include:\n1. Repetitive Sequences\r#\rRepetitive regions of the genome can be difficult to assemble because short reads may map to multiple locations. This can result in gaps or misassemblies.\n2. Coverage Gaps\r#\rIn areas with low sequencing coverage, the assembly may be incomplete or contain errors. Ensuring sufficient coverage is essential for accurate assembly.\n3. Error Correction\r#\rSequencing errors, such as base miscalls or insertions/deletions, can introduce inaccuracies in the assembly. These errors must be carefully corrected to improve the quality of the assembled genome.\n4. Computational Requirements\r#\rThe process of assembling large genomes from millions of short reads can be computationally expensive, requiring substantial memory and processing power. Optimizing algorithms to handle large datasets efficiently is an ongoing challenge.\nFuture Directions\r#\rWith advances in next-generation sequencing technologies, such as long-read sequencing (e.g., PacBio and Oxford Nanopore), sequence assembly is expected to become more accurate and efficient. These technologies can generate much longer reads, reducing the complexity of the assembly process and improving the accuracy of contig assembly.\nAdditionally, machine learning and artificial intelligence are being explored to enhance the performance of sequence assembly tools, enabling faster and more accurate genome reconstruction.\nConclusion\r#\rSequence assembly is a cornerstone of modern genomics, enabling researchers to generate complete genome sequences from short DNA fragments. Whether through de novo or reference-guided assembly, this process provides critical insights into the genetic makeup of organisms. Although challenges remain, ongoing advancements in sequencing technology and computational methods continue to improve the efficiency and accuracy of sequence assembly, driving forward our understanding of biology and genetics.\n"},{"id":5,"href":"/docs/content/pharmacology/general_abbreviations/","title":"General_abbreviations","section":"Pharmacology","content":"\rCommon Abbreviations\r#\rCommon Abbreviations in Prescriptions\r#\rHave you ever wondered what the weird abbreviations like \u0026ldquo;p.o\u0026rdquo; or \u0026ldquo;p.e\u0026rdquo; mean? These are, in fact, common abbreviations used in prescriptions to help pharmacologists prepare the drugs and instructions you see when you get your medications.\nHere is a handy list of commonly used abbreviations. Note that these terms might or might not be used and will depend on how the professionals are trained:\nAbbreviation Description AA Of each (ana) AAU Both ears (auris utraque) AC Before meals (ante cibum) AM In the morning (ante meridiem) AD Right ear (auris dexter) AD US Up to (ad usque) AQ Water (aqua) AS Left ear (auris sinister) ATC Around the clock BB By mouth (per os) BID Twice a day (bis in die) BM Bowel movement (bucco-masseteric) C With (cum) CAPS Capsules CONC Concentrated DIL Dilute DIV Divide EC Enteric coated EOD Every other day FT Make, prepare (fac, fiat) GT Drops (guttae) H Hour (hora) HS At bedtime (hora somni) IN Intranasal (intra nasal) IM Intramuscular (intra muscular) IV Intravenous (intra venous) M Mix (misce) M ET N Half and half (misce et nota) MIXT Mixture NON REP Do not repeat (non repetatur) OD Once daily (omni die) OD Right eye (oculus dexter) OS Left eye (oculus sinister) OU Both eyes (oculi utroque) PC After meals (post cibum) PID Twice a day (post in die) PRN As needed (pro re nata) Q Every (quaque) QH Every hour (quaque hora) QHS Every night at bedtime (quaque hora somni) QID Four times a day (quater in die) SL Sublingual (sub lingual) SS One-half (semis) STAT Immediately (statim) TAB Tablet TID Three times a day (ter in die) "},{"id":6,"href":"/docs/content/pharmacology/general_history/","title":"General_histroy","section":"Pharmacology","content":"\rHistory of Pharmacology\r#\rThe field of pharmacology has a rich history that spans thousands of years, reflecting humanity\u0026rsquo;s quest to understand and manipulate the effects of drugs on the body. This tutorial will explore key milestones and developments in the history of pharmacology.\nAncient Practices\r#\rPharmacology can be traced back to ancient civilizations, where herbal remedies were used to treat various ailments. Early records from ancient Egypt, China, and India describe the use of plants and minerals in medicinal preparations. The Ebers Papyrus (circa 1550 BCE) from Egypt is one of the oldest medical texts, listing numerous remedies derived from plants.\nThe Greeks and Romans\r#\rThe Greeks made significant contributions to the field, with philosophers such as Hippocrates (circa 460–370 BCE) emphasizing the importance of observing the effects of substances on the human body. Galen (circa 129–216 CE), a Roman physician, further advanced pharmacology by conducting experiments and establishing principles of drug action based on the four humors theory.\nThe Middle Ages\r#\rDuring the Middle Ages, the study of pharmacology stagnated in Europe but flourished in the Islamic world. Scholars like Avicenna (Ibn Sina) wrote influential texts, such as \u0026ldquo;The Canon of Medicine,\u0026rdquo; which compiled knowledge on herbs and drugs and emphasized the importance of empirical observation.\nThe Renaissance\r#\rThe Renaissance sparked renewed interest in science and medicine, leading to the establishment of botanical gardens and the systematic study of plants for medicinal purposes. Paracelsus (1493–1541) revolutionized pharmacology by advocating the use of chemicals in medicine and emphasizing the concept of dose-response.\nThe 18th and 19th Centuries\r#\rThe 18th century saw the emergence of modern chemistry, paving the way for the isolation of active ingredients from plants. In the 19th century, the discovery of morphine (from opium) and quinine (from cinchona bark) marked significant advancements in the understanding of drug actions and their therapeutic uses.\nThe 20th Century and Beyond\r#\rThe 20th century witnessed explosive growth in pharmacology, driven by advancements in biochemistry and molecular biology. The development of synthetic drugs, antibiotics, and vaccines transformed medicine. Regulatory agencies, such as the FDA, were established to ensure drug safety and efficacy.\nToday, pharmacology continues to evolve with innovations in pharmacogenomics, biotechnology, and personalized medicine, offering new insights into drug actions and individual responses to treatment.\nConclusion\r#\rThe history of pharmacology is a testament to humanity\u0026rsquo;s enduring quest for knowledge and healing. Understanding this history helps us appreciate the complexity of drug interactions and the ongoing advancements in the field.\nFeel free to add more sections or details as needed!\n"},{"id":7,"href":"/docs/content/pharmacology/general_medication_origin/","title":"General_medication_origin","section":"Pharmacology","content":"\rMedication Sourcing and Origins\r#\rSources of Medication\r#\rIn modern medicine, medication refers to the active ingredient or one specific chemical exerting effect on our body. These are often purified from natural sources and through the study of such compounds, more efficacious synthetic forms are created.\nIn general, sources of modern medicine can be divided into:\nNatural Derivatives Semi-Synthetic Synthetic Natural Source of Medication\r#\rPlant Derivatives\r#\rThe use of medicinal plants can date back to ancient Sumeria (3,000 BC), where hundreds of medicinal plants are listed on clay tablets. Although ancient people didn\u0026rsquo;t understand the mechanisms behind them, our ancestors learned to use these plants for curing diseases.\nSince the 19th century, active compounds in these plants have been constantly discovered and purified to create what we now know as medicine. Some well-known plant-derived drugs include:\nMorphine: derived from the opium poppy (Papaver somniferum), used as a pain reliever. Aspirin: originally derived from willow bark, used as a pain reliever and anti-inflammatory agent. Quinine: derived from the bark of the cinchona tree, used to treat malaria. Digitalis: derived from the foxglove plant, used to treat heart conditions. Animal Derivatives\r#\rWith advancements in modern medicine and an understanding of physiology, some well-understood compounds derived from animals are also used as medication. For example:\nInsulin: originally extracted from the pancreas of pigs and cows, used to treat diabetes. Heparin: derived from the mucosal tissues of pigs and cows, used as an anticoagulant. Conotoxins: derived from the venom of cone snails, used as pain relievers and in neurological research. Microorganism-Derived Drugs\r#\rStudies of microorganisms such as bacteria, fungi, and algae have also allowed us to identify a variety of bioactive compounds, mostly for the use of antibiotics. Examples include:\nPenicillin: derived from the fungus Penicillium, used as an antibiotic. Streptomycin: derived from the bacterium Streptomyces, used as an antibiotic. Cyclosporine: derived from a fungus found in Norwegian soil, used as an immunosuppressant. Artemisinin: derived from the sweet wormwood plant, used as an antimalarial. Semi-Synthetic Compounds\r#\rSome drugs are derived from natural sources but undergo chemical modification to improve their properties. Examples include:\nMorphine derivatives: such as codeine and oxycodone, which are semi-synthetic opioids used as pain relievers. Penicillin derivatives: such as amoxicillin and ampicillin, which are semi-synthetic antibiotics derived from the natural compound penicillin. Statins: such as lovastatin and atorvastatin, which are semi-synthetic cholesterol-lowering drugs derived from natural compounds found in fungi. Synthetic Compounds\r#\rMany drugs are synthesized through chemical reactions in laboratories. Examples include:\nAcetaminophen (paracetamol): used as a pain reliever and fever reducer. Albuterol: used as a bronchodilator to treat asthma and chronic obstructive pulmonary disease (COPD). Simvastatin: used to lower cholesterol levels in the treatment of hyperlipidemia. Metformin: used to treat type 2 diabetes by lowering blood sugar levels. References\r#\rInsert references here if needed.\n"},{"id":8,"href":"/docs/content/pharmacology/general_regulations/","title":"General_regulations","section":"Pharmacology","content":"\rClassification of Drugs By Law\r#\rDrug Classification\r#\rIn general, drugs used in healthcare can be classified into four groups by law, including Over-the-Counter (OTC) drugs, prescription drugs, and illegal drugs, ranked from low to high regulation levels.\nClass Legal Status Examples Over-the-Counter (OTC) Drugs Available for purchase without a prescription. Pain relievers, antacids, allergy medications. Prescription Drugs Available only with a prescription from a licensed healthcare professional. Antibiotics, antidepressants, opioids. Illegal Drugs Prohibited by law for recreational use, sale, or possession. Heroin, LSD, marijuana (in some jurisdictions). OTC Drugs\r#\rDrugs labeled as OTC are generally used for common ailments, chronic conditions, preventive care, first aid, and dietary supplements.\nCurrent Use\r#\rCommon Ailments: OTC drugs are commonly used to alleviate symptoms of minor ailments such as headaches, colds, coughs, allergies, and indigestion. Common examples include acetaminophen (Tylenol®), ibuprofen (Advil®), and aspirin.\nChronic Conditions: Some OTC drugs are also used for managing chronic conditions like acid reflux, joint pain, and allergies, providing relief for recurring symptoms. Examples include loratadine (Claritin®) and cetirizine (Zyrtec®) for allergies, as well as bismuth (Pepto-Bismol®) for acid reflux.\nPreventive Care: Certain OTC drugs, such as multivitamins, supplements, and contraceptives, are used for preventive care, helping individuals maintain their health and well-being.\nFirst Aid: OTC drugs like pain relievers, antiseptics, and adhesive bandages are essential components of first-aid kits, used to treat minor injuries and wounds.\nDietary Supplements: Many people use OTC dietary supplements to complement their diets, aiming to address nutritional deficiencies or support specific health goals.\nOTC drugs provide convenient access to medications, allowing individuals to quickly address minor health concerns without the need for a prescription or a visit to a healthcare provider. However, due to their accessibility and cost-effectiveness, misuse and addiction have become major concerns for OTCs, as described by Schifano et al., 2021. According to the review, misuse most often occurs in patients already suffering from health conditions or psychiatric disorders, with cough mixtures containing dextromethorphan (DXM), codeine, and nasal decongestants containing pseudoephedrine being common sources of misuse.\nIt is also important to note that these medications can still have side effects, even though they are generally considered safe. For example, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or aspirin can increase the risk of heart attack, stroke, or gastrointestinal bleeding, especially with long-term or high-dose use.\nPrescriptions\r#\rPrescription drugs are typically more potent and specialized but may also be more harmful or addictive than over-the-counter (OTC) drugs. In North America, ℞, usually printed as \u0026ldquo;Rx,\u0026rdquo; is used as an abbreviation for the word \u0026ldquo;prescription.\u0026rdquo; Therefore, a prescription from a licensed healthcare provider, such as a physician, nurse practitioner, or dentist, is required. These medications are regulated by government agencies to ensure their safety, efficacy, and proper use.\nA major concern in this class of drugs is antibiotic resistance, which refers to the ability of pathogens (organisms that we want to kill) to gain resistance through the misuse or overuse of antibiotics. The exact mechanisms behind antibiotic resistance are complex, and we will discuss it later in this tutorial. In general, to reduce antibiotic resistance, it is important for patients to complete the full course of antibiotics as prescribed.\nIllegal Drugs\r#\rIllegal drugs are often highly addictive and harmful to the body and are not commonly used for the treatment of diseases due to their side effects greatly outweighing their benefits. The definition and list of illegal drugs vary between countries, and some drugs classified as illegal may actually be available by prescription in others. Common illegal drugs include 3,4-methylenedioxymethamphetamine (MDMA), gamma-Hydroxybutyric acid (GHB), and phencyclidine (PCP).\nPharmacopeia Websites\r#\rPharmacopeia refers to an official publication containing a list of medicinal drugs with their effects and directions for their use. Depending on the country, pharmacopeia can be found on different government websites:\nCountry Pharmacopeia United States United States Pharmacopeia (USP) Europe European Pharmacopoeia (Ph. Eur.) United Kingdom British Pharmacopoeia (BP) Japan Japanese Pharmacopoeia (JP) India Indian Pharmacopoeia (IP) China Chinese Pharmacopoeia (ChP) France French Pharmacopoeia (Pharmacopée Française) Germany German Pharmacopoeia (Deutsches Arzneibuch, DAB) Russia Russian Pharmacopoeia (Pharmacopoea Rossica) Brazil Brazilian Pharmacopoeia (Farmacopeia Brasileira) Australia Australian Medicines Handbook (AMH) References\r#\rSchifano, F., Chiappini, S., Miuli, A., Mosca, A., Santovito, M. C., Corkery, J. M., Guirguis, A., Pettorruso, M., Di Giannantonio, M., \u0026amp; Martinotti, G. (2021). Focus on Over-the-Counter Drugs\u0026rsquo; Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants. Frontiers in Psychiatry, 12, 657397. https://doi.org/10.3389/fpsyt.2021.657397 "},{"id":9,"href":"/docs/content/pharmacology/pharmacokinetics_introduction/","title":"Pharmacokinetics_introduction","section":"Pharmacology","content":"\rIntroduction to Pharmacokinetics\r#\rIntroduction\r#\rAs mentioned in the introduction, pharmacokinetics studies how the body interacts with drugs through absorption, distribution, metabolism, and elimination (ADME). Before we talk about each individually, there are a few fundamental concepts you should understand.\nThe Fluid Mosaic Model\r#\rWhen we talk about medications, it is really hard not to mention some fundamental concepts from cell biology and physiology. But don\u0026rsquo;t panic; they won\u0026rsquo;t be so hard to understand.\nJust like the skin that separates our internal organs from the external environment, the biological membrane is a layer of phospholipid bilayer that separates the content inside the cell from the content outside the cell.\nIn chemistry, there is a term called hydrophobic, which literally means \u0026ldquo;water-fearing,\u0026rdquo; and a term hydrophilic, which means \u0026ldquo;water-loving.\u0026rdquo; Interchangeably, lipophilic and lipophobic can also be used, and you guessed it, it literally means \u0026ldquo;lipid-loving\u0026rdquo; and \u0026ldquo;lipid-fearing.\u0026rdquo;\nPhospholipids are a type of amphipathic molecule (a molecule with both hydrophilic and hydrophobic regions) where one fatty acid from a triglyceride molecule is removed and replaced with a phosphate group (1 phosphate group, 2 fatty acids, and 1 glycerol).\nThe fluid mosaic model describes that these biological membranes are:\nSemi-permeable "},{"id":10,"href":"/about/","title":"About Piggy Botanist","section":"Welcome to My Website","content":"\rAbout Piggy Botanist:\r#\rMy name is Jeremy Chang, but you can call me Piggy Botanist.\nI earned my Bachelor of Science (BSc) with a major in Biomedical Science and a Master\u0026rsquo;s degree (MSc) specializing in Animal Science and Microbiology at the University of Guelph, where I studied from 2018 to 2023. I am currently pursuing a PhD in the Department of Computer Science at McGill University.\nI consider myself neither a complete biologist nor a full-fledged computer scientist; rather, I embody a unique intersection of both fields. This interdisciplinary background has granted me valuable experience in biological experiments within a wet lab environment, as well as in a traditional computer science lab focused on algorithm development, machine learning models, and software implementations. These experiences have equipped me with a solid foundation in bioinformatics, allowing me to bridge the gap between biology and computer science.\nDue to confidentiality, I cannot completely disclose my research project, but I am working on improving the process of metagenomics binning by utilize crowd-sourcing data in the training of AI agent. We hope to develop a bioinformatics analysis pipeline that enables the reconstruction of metagenomics assembled genome (MAG) for bacteria, fungi, protists, and virus from metagenomics samples collected from different enviornments which can include soil, fecal samples, fresh water, and environmental swabs.\nExperience:\r#\rPublications:\r#\rQi, N., Zhan, X., Milmine, J., Chang, K.-H., \u0026amp; Li, J. (2024). A novel thermophilic strain of Bacillus subtilis with antimicrobial activity and its potential application in solid-state fermentation of soybean meal. Microbiology spectrum, 12(4), e0278423. https://doi.org/10.1128/spectrum.02784-23\nQi, N., Zhan, X., Milmine, J., Sahar, M., Chang, K. H., \u0026amp; Li, J. (2023). Isolation and characterization of a novel hydrolase-producing probiotic Bacillus licheniformis and its application in the fermentation of soybean meal. Frontiers in nutrition, 10, 1123422. https://doi.org/10.3389/fnut.2023.1123422\n"}]